ARCHIVES

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

Seffrin, Thomas Lead List of ACS Exec. VP Candidates, Reportedly

May 1, 1992

Judge Hears Arguments In Fisher’s Privacy Act Suit Over Databases

January 19, 1996

RFPs Available, Contract Awards, Sole Source Negotiations

June 25, 1976

NCI Nears Confrontation Over Construction As OMB Continues Obstructionist Policies

July 11, 1975

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

Letter: ORI And Plotkin Should Release Report

June 23, 1995